Fecal incontinence is associated with the inability of individuals to
control bowel movements, causing unexpected leakage of stool leading
to complete loss of bowel control. Fecal incontinence is also known
as bowel incontinence. It is caused due to constipation, diarrhea,
and nerve damage which is linked with aging. Fecal incontinence is of
two types: urge incontinence (an individual is not able to resist the
urge to excrete) and passive incontinence (an individual is not aware
of the sensation before soiling oneself).
Fecal incontinence can be caused due to muscle damage associated with
damage of anal sphincter. This type of muscle damage takes place
during child birth. Nerve damage can also led to fecal incontinence
leading to loss of control over anal sphincter. The primary reason
for nerve damage can be diseases such as multiple sclerosis,
diabetes, and Alzheimer’s. Other causes of fecal incontinence are
surgery, rectal prolapse, and rectocele. Complications associated
with fecal incontinence include emotional distress and skin
irritation. Emotional distress is also linked with the loss of bowel
control, leading to shame, embarrassment, anger, frustration, and
depression.
Fecal incontinence diagnosis is carried out through medical
examination test, which include digital rectal examination, balloon
expulsion test, anal manometry, proctography, proctosigmoidoscopy,
colonoscopy, and magnetic resonance imaging (MRI). Treatment of fecal
incontinence involves usage of anti-diarrheal drugs such as
loperamide hydrochloride, laxatives (psyllium), and injectable
bulking agents such as hyaluronate sodium. Surgery can also be
prescribed in certain adverse cases. Different types of surgical
procedures used to treat fecal incontinence are sphincteroplasty,
surgical correction of rectocele or hemorrhoids, sphincter
replacement, colostomy, or bowel diversion.
Around 1.4% of the
general population over 40 years of age is affected by fecal
incontinence and nearly 3% to 15% of the population is affected by
constipation. According to the Continence Foundation of Australia,
nearly 4.8 million people in Australia experience bladder or bowel
control problems. Fecal incontinence affects nearly 20% of men and
approximately 12.9% of women in Australia.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33698
Major drivers of the global fecal incontinence market are increase in
prevalence of diseases which result in the loss of muscle control and
lead to gastrointestinal disorders, rise in the pharmaceutical
industry, surge in demand for fecal incontinence products, growing
awareness about personal hygiene, rise in geriatric population, and
technological innovation in continence product development. Factors
restraining the market are social stigma, emotional distress,
increasing cost of health care suppliers, inadequate knowledge about
the treatment of fecal incontinence in developing countries, and
stringent regulations and reimbursement policies.
The global fecal incontinence market can be segmented into five
regions: North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. North America is expected to hold a major
share of the market in terms of revenue. Dominance of the region is
attributed to higher acceptance of fecal incontinence products,
increase in awareness, presence of major market leaders in the
region, better health care facilities in terms of health care
expenditure, and increase in prevalence of chronic diseases. The
market in Europe trails closely behind the North America market.
The fecal incontinence market in Asia Pacific is expected to expand
at a high CAGR during the forecast period due to rapidly increasing
geriatric population, health care infrastructure, public and private
collaboration to spread awareness among individuals about personal
hygiene, higher rate of adoption of newer technology in product
development, fast growing economies such as India, and expansion of
business and product portfolio by major market players in the region.
The market in Latin America and Middle East & Africa is expected
to provide a lucrative growth opportunity during the forecast period
due to favorable economic reforms in promoting the health care
industry.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=33698<ype=S
Major players operating in the global fecal incontinence market are
Kimberly-Clark Corporation, Medline Industries Inc., Coloplast A/S,
and B. Braun Melsungen AG.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment